Join Digital Education Committee Member and podcast host Melissa E. Middeldorp, MPH, PhD, and her guests Eue-Keun Choi, MD, PhD, and Sandeep Prabhu, MBBS, PhD for this week’s Lead episode. This episode was recorded LIVE at APHRS 2025 in Yokohama, Japan.
The DECAF trial investigated whether continuing regular caffeinated coffee consumption versus complete abstinence affected the recurrence of atrial fibrillation (AF) or atrial flutter in patients after successful cardioversion. Over six months in this randomized study of 200 adults, those who drank at least one cup of caffeinated coffee daily had a significantly lower rate of AF or flutter recurrence compared to those who abstained (47% vs. 64%), suggesting moderate coffee intake may be safe and potentially beneficial for rhythm stability in this setting.
Learning Objectives
-
Evaluate the impact of caffeinated coffee consumption versus abstinence on atrial fibrillation recurrence following cardioversion.
-
Interpret the design and key outcomes of the DECAF randomized clinical trial and their relevance to clinical practice.
-
Apply the trial findings to patient counseling regarding caffeine intake and atrial fibrillation management.
Article Authors
Christopher X. Wong, MBBS, MPH, PhD; Christopher C. Cheung, MD, MPH; Gabrielle Montenegro, BA, Hannah H. Oo, BS; Isabella J. Peña, BA; Janet J. Tang, MPH, PhD; Samuel J. Tu, MBBS; Grace Wall, BA1; Thomas A. Dewland, MD; Joshua D. Moss, MD; Edward P. Gerstenfeld, MD; Zian H. Tseng, MD, MAS; Henry H. Hsia, MD; Randall J. Lee, MD, PhD; Jeffrey E. Olgin, MD; Vasanth Vedantham, MD; Melvin M. Scheinman, MD; Catherine Lee, PhD; Prashanthan Sanders, MBBS, PhD; Gregory M. Marcus, MD, MAS
Podcast Contributors
Melissa E. Middeldorp, MPH, PhD
Eue-Keun Choi, MD, PhD
Sandeep Prabhu, MBBS, PhD
Article and Speaker information: Download
Listen on Heart Rhythm 365
Listen on iHeart
Listen on Spotify
Listen on Apple Podcasts
Topic
- The Lead
Resource Type
- Podcasts
Related Resources
The Lead
Podcasts
The Lead Episode 140: A Discussion of Atrial Cardiomyopathy: Markers and Outcomes
March 12, 2026
The Lead
Podcasts
The Lead Episode 139: Improving Outcomes of Atrial Fibrillation Ablation by Integrated Personalized Lifestyle Interventions: A Randomized Control Trial
March 5, 2026
The Lead
Podcasts
The Lead Episode 138: A Discussion of A Discussion of Safety, Efficacy, and Mid-Term Outcomes of Pulsed Field Ablation for Cavotricuspid Isthmus–Dependent Flutter: Real-World Data From a Major Health System Registry
February 26, 2026